Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.
Ieranò C, Portella L, Lusa S, Salzano G, D'Alterio C, Napolitano M, Buoncervello M, Macchia D, Spada M, Barbieri A, Luciano A, Barone MV, Gabriele L, Caraglia M, Arra C, De Rosa G, Scala S. Ieranò C, et al. Among authors: luciano a. Nanoscale. 2016 Apr 14;8(14):7562-71. doi: 10.1039/c5nr06335c. Nanoscale. 2016. PMID: 26983756
Inhibition of stromal CXCR4 impairs development of lung metastases.
D'Alterio C, Barbieri A, Portella L, Palma G, Polimeno M, Riccio A, Ieranò C, Franco R, Scognamiglio G, Bryce J, Luciano A, Rea D, Arra C, Scala S. D'Alterio C, et al. Among authors: luciano a. Cancer Immunol Immunother. 2012 Oct;61(10):1713-20. doi: 10.1007/s00262-012-1223-7. Epub 2012 Mar 8. Cancer Immunol Immunother. 2012. PMID: 22399057 Free PMC article.
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases.
Portella L, Vitale R, De Luca S, D'Alterio C, Ieranò C, Napolitano M, Riccio A, Polimeno MN, Monfregola L, Barbieri A, Luciano A, Ciarmiello A, Arra C, Castello G, Amodeo P, Scala S. Portella L, et al. Among authors: luciano a. PLoS One. 2013 Sep 13;8(9):e74548. doi: 10.1371/journal.pone.0074548. eCollection 2013. PLoS One. 2013. PMID: 24058588 Free PMC article.
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways.
Bruzzese F, Pucci B, Milone MR, Ciardiello C, Franco R, Chianese MI, Rocco M, Di Gennaro E, Leone A, Luciano A, Arra C, Santini D, Caraglia M, Budillon A. Bruzzese F, et al. Among authors: luciano a. Cell Death Dis. 2013 Oct 24;4(10):e878. doi: 10.1038/cddis.2013.406. Cell Death Dis. 2013. PMID: 24157872 Free PMC article.
475 results